Improved Neutralisation of the SARS-CoV-2 Omicron Variant following a Booster Dose of Pfizer-BioNTech (BNT162b2) COVID-19 Vaccine.
Basile K, Rockett RJ, McPhie K, Fennell M, Johnson-Mackinnon J, Agius JE, Fong W, Rahman H, Ko D, Donavan L, Hueston L, Lam C, Arnott A, Chen SC, Maddocks S, O'Sullivan MV, Dwyer DE, Sintchenko V, Kok J.
Basile K, et al. Among authors: dwyer de.
Viruses. 2022 Sep 13;14(9):2023. doi: 10.3390/v14092023.
Viruses. 2022.
PMID: 36146829
Free PMC article.